WallStreetZenWallStreetZen

NYSE: TBI
Trueblue Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for TBI

Based on 1 analyst offering 12 month price targets for Trueblue Inc

Min Forecast
$8.00+33.56%
Avg Forecast
$8.00+33.56%
Max Forecast
$8.00+33.56%

Should I buy or sell TBI stock?

Based on 1 analyst offering ratings for Trueblue Inc.

Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their TBI stock forecasts and price targets.

TBI stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-08-06

1 of 1

Forecast return on equity

Is TBI forecast to generate an efficient return?

Company
8.52%
Industry
61.31%
Market
-21.03%
TBI's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is TBI forecast to generate an efficient return on assets?

Company
3.87%
Industry
10.29%
TBI is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

TBI earnings per share forecast

What is TBI's earnings per share in the next 2 years based on estimates from 1 analyst?

Avg 1 year Forecast
-$0.57
Avg 2 year Forecast
$0.87

TBI revenue forecast

What is TBI's revenue in the next 2 years based on estimates from 1 analyst?

Avg 1 year Forecast
$1.6B+2.75%
Avg 2 year Forecast
$1.7B+12.73%
TBI's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

TBI revenue growth forecast

How is TBI forecast to perform vs Staffing & Employment Services companies and vs the US market?

Company
2.75%
Industry
10.69%
Market
131.06%
TBI's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
TBI's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

TBI vs Staffing & Employment Service Stocks

TickerPricePrice TargetUp/downsideConsensus
TBI$5.99$8.00+33.56%Buy
HQI$10.00$13.00+30.00%Buy
ATLN$3.96N/AN/A
MHH$7.50N/AN/A
BGSF$7.76$9.00+15.98%Strong Buy
View Top Staffing & Employment Service Stocks

Trueblue Stock Forecast FAQ

Is Trueblue Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NYSE: TBI) stock is to Buy TBI stock.

Out of 1 analyst, 0 (0%) are recommending TBI as a Strong Buy, 1 (100%) are recommending TBI as a Buy, 0 (0%) are recommending TBI as a Hold, 0 (0%) are recommending TBI as a Sell, and 0 (0%) are recommending TBI as a Strong Sell.

If you're new to stock investing, here's how to buy Trueblue stock.

What is TBI's earnings growth forecast for 2025-2026?

(NYSE: TBI) Trueblue's forecast annual earnings growth rate of N/A is not forecast to beat the US Staffing & Employment Services industry's average forecast earnings growth rate of 10.95%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 54.34%.

Trueblue's earnings in 2025 is -$33,848,000.On average, 1 Wall Street analyst forecast TBI's earnings for 2025 to be -$17,043,495, with the lowest TBI earnings forecast at -$17,043,495, and the highest TBI earnings forecast at -$17,043,495.

In 2026, TBI is forecast to generate $26,013,755 in earnings, with the lowest earnings forecast at $26,013,755 and the highest earnings forecast at $26,013,755.

What is TBI's revenue growth forecast for 2025-2026?

(NYSE: TBI) Trueblue's forecast annual revenue growth rate of 2.75% is not forecast to beat the US Staffing & Employment Services industry's average forecast revenue growth rate of 10.69%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 131.06%.

Trueblue's revenue in 2025 is $1,534,863,000.On average, 1 Wall Street analysts forecast TBI's revenue for 2025 to be $47,157,555,949, with the lowest TBI revenue forecast at $47,157,555,949, and the highest TBI revenue forecast at $47,157,555,949.

In 2026, TBI is forecast to generate $51,735,677,848 in revenue, with the lowest revenue forecast at $51,735,677,848 and the highest revenue forecast at $51,735,677,848.

What is TBI's forecast return on assets (ROA) for 2025-2026?

(NYSE: TBI) forecast ROA is 3.87%, which is lower than the forecast US Staffing & Employment Services industry average of 10.29%.

What is TBI's Price Target?

According to 1 Wall Street analyst that have issued a 1 year TBI price target, the average TBI price target is $8.00, with the highest TBI stock price forecast at $8.00 and the lowest TBI stock price forecast at $8.00.

The Wall Street analyst predicted that Trueblue's share price could reach $8.00 by Aug 6, 2026. The average Trueblue stock price prediction forecasts a potential upside of 33.56% from the current TBI share price of $5.99.

What is TBI's Earnings Per Share (EPS) forecast for 2025-2026?

(NYSE: TBI) Trueblue's current Earnings Per Share (EPS) is -$1.17. On average, analysts forecast that TBI's EPS will be -$0.57 for 2025, with the lowest EPS forecast at -$0.57, and the highest EPS forecast at -$0.57. In 2026, TBI's EPS is forecast to hit $0.87 (min: $0.87, max: $0.87).

What is TBI's forecast return on equity (ROE) for 2025-2026?

(NYSE: TBI) forecast ROE is 8.52%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.